Bibliography
- National Institutes of Health NIH State-of-the-Science Conference Statement on Manifestations and Management of Chronic Insomnia in Adults. Available from: http://consensus.nih.gov/previous.htm 2005.22:1-30
- Zisapel N. Sleep and sleep disturbances: biological basis and clinical implications. Cell Mol Life Sci 2007;64:1174-86
- Ohayon MM, Zulley J, Guilleminault C, How age and daytime activities are related to insomnia in the general population: consequences for older people. J Am Geriatr Soc 2001;49:360-6
- Hajak G. Epidemiology of severe insomnia and its consequences in Germany. Eur Arch Psychiatry Clin Neurosci 2001;251:49-56
- Hardeland R. New approaches in the management of insomnia: weighing the advantages of prolonged-release melatonin and synthetic melatoninergic agonists. Neuropsychiatr Dis Treat 2009;5:341-54
- Daley M, Morin CM, LeBlanc M, The economic burden of insomnia: direct and indirect costs for individuals with insomnia syndrome, insomnia symptoms, and good sleepers. Sleep 2009;32:55-64
- Glass J, Lanctot KL, Herrmann N, Sedative hypnotics in older people with insomnia: meta-analysis of risks and benefits. BMJ 2005;331:1169
- Lieberman JA. Update on the safety considerations in the management of insomnia with hypnotics: incorporating modified-release formulations into primary care. Prim Care Companion J Clin Psychiatry 2007;9:25-31
- Bourin M. The problems with the use of benzodiazepines in elderly patients. Encephale 2010;36:340-7
- Morin CM, Belanger L, Bastien C, Long-term outcome after discontinuation of benzodiazepines for insomnia: a survival analysis of relapse. Behav Res Ther 2005;43:1-14
- Lemoine P, Ni T, Laudon M, Prolonged-release melatonin improves sleep quality and morning alertness in insomnia patients aged 55 years and older and has no withdrawal effects. J Sleep Res 2007;16:372-80
- Wade AG, Ford I, Crawford G, Efficacy of prolonged release melatonin in insomnia patients aged 55-80 years: quality of sleep and next-day alertness outcomes. Curr Med Res Opin 2007;23:2597-605
- Luthringer R, Muzet M, Zisapel N, The effect of prolonged-release melatonin on sleep measures and psychomotor performance in elderly patients with insomnia. Int Clin Psychopharmacol 2009;24:239-49
- Wade AG, Ford I, Crawford G, Nightly treatment of primary insomnia with prolonged release melatonin for 6 months: a randomized placebo controlled trial on age and endogenous melatonin as predictors of efficacy and safety. BMC Med 2010;8:51
- Melatonin for primary insomnia? Drug Ther Bull 2009;47:74-7
- Becher H, Kostev K, Schroder-Bernhardi D. Validity and representativeness of the "Disease Analyzer" patient database for use in pharmacoepidemiological and pharmacoeconomic studies. Int J Clin Pharmacol Ther 2009;47:617-26
- ICD-10 codes German Modification 2007. 2007
- Anatomical classification guidelines 2007. European Pharmaceutical Research Association (EPHMRA), 2007
- Deutsche Hauptstelle fur Suchtfragen Pressekonferenz am 7.4.2010 in BerlinVorstellung des Jahrbuchs SUCHT 2010. Available from: http:// www.sucht.lawicki.de/index.php?option=com content&view=article&id=491:Jahrbuch-sucht-2010-suchtmittelkonsum-bleibt-stabil-auf-extrm-hohem-niveau-&catid-1:aktuelle-nachrichten<mid=18 2010
- Schwabe U, Paffrath D. Arzneimittelverordnungsreport 2009. Springer Medizin Verlag; Heidelberg: 2009
- Deutsche Hauptstelle fur SuchtfragenDHS Jahrbuch SUCHT 2010. Available from: http://www.dhs.de 2010
- Garfinkel D, Zisapel N, Wainstein J, Facilitation of benzodiazepine discontinuation by melatonin: a new clinical approach. Arch Intern Med 1999;159:2456-60
- Dagan Y, Zisapel N, Nof D, Rapid reversal of tolerance to benzodiazepine hypnotics by treatment with oral melatonin: a case report. Eur Neuropsychopharmacol 1997;7:157-60
- Vissers FH, Knipschild PG, Crebolder HF. Is melatonin helpful in stopping the long-term use of hypnotics? A discontinuation trial. Pharm World Sci 2007;29:641-6
- Aldhous M, Franey C, Wright J, Plasma concentrations of melatonin in man following oral absorption of different preparations. Br J Clin Pharmacol 1985;19:517-21
- Oude Voshaar RC, Gorgels WJ, Mol AJ, Long-term outcome of two forms of randomised benzodiazepine discontinuation. Br J Psychiatry 2006;188:188-9
- Available from: http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Procedural_steps_taken_and_scientific_information_after_authorisation/human/000695/WC500026810.pdf 2011
- Verdoux H, Gaudron Y, Tournier M. Transition in care in persons with antidepressant prescription in naturalistic conditions. Fam Pract 2011;28:400-5